Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN116640737A reveals novel BsER mutants for chiral ketone reduction. Enables high-purity pharmaceutical intermediates with reduced manufacturing costs and enhanced supply reliability.
Patent CN113024454A reveals a novel synthesis for brigatinib intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN1761742A reveals recombinant lactonase technology for efficient D-pantolactone synthesis, offering cost reduction and supply stability for vitamin B5 manufacturers.
Advanced chiral resolution technology for 2-heterocyclic dihydropyrimidines using binaphthol phosphate. Delivers >99% optical purity for scalable hepatitis B drug manufacturing.
Novel gold-catalyzed route ensures safe scalable production of high-purity nucleoside analogs with significant cost and supply chain advantages for pharmaceutical partners.
Patent CN108118035B reveals high-concentration enzymatic route reducing costs and improving purity for global supply chains.
Novel enzymatic route for S-indoline-2-carboxylic acid ensures >99% ee purity and simplified processing for reliable pharmaceutical intermediate supply chains.
Novel coumarin-biphenyl compounds for hypertension treatment. High-yield synthesis via click chemistry. Reliable supply for API development and cost reduction.
Patent CN104152506B reveals a crude enzyme system for high-purity pharmaceutical intermediates. This method offers significant supply chain and cost advantages for global buyers.
Patent CN116589417B reveals ionic liquid catalysis for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable green chemistry.
Patent CN1032361C details novel imidazopyridazine derivatives with anti-asthmatic activity. Learn about scalable synthesis routes and cost-effective manufacturing strategies for high-purity intermediates.
Novel patent CN116102465B details high-yield diamine synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel zirconium-catalyzed process for high-purity PPI intermediates. Reduces costs and improves supply chain reliability for pharmaceutical manufacturing.
Novel ADH mutant enables high-purity Brivaracetam intermediate production with superior stereoselectivity and cost-effective supply chain solutions.
Novel patent CN116102465B enables high-purity diamine production. Eliminates palladium catalysts and toxic solvents for significant cost reduction and supply chain reliability.
Patent CN101029049B reveals a breakthrough in recyclable cinchona alkaloid ligands for synthesizing paclitaxel and docetaxel side chains, offering significant cost reduction and supply chain stability.
Patent CN101029049B reveals a breakthrough in recyclable cinchona alkaloid ligands for paclitaxel synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel Silodosin preparation method reduces impurities significantly. High yield industrial process for reliable pharmaceutical intermediate supply chain.
Patent CN103342705A details a high-yield copper-catalyzed route for pyrrolo[1,2-a]quinoxaline derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108586427B details a safe, scalable route for atorvastatin intermediates, eliminating toxic cyanide usage while ensuring high purity for global supply chains.